Idra stock zacks

IDRA Stock Price, Forecast & News (Idera Pharmaceuticals) Idera Pharmaceuticals' stock was trading at $1.38 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IDRA shares have decreased by 7.2% and is now trading at $1.28.

IDRA investment & stock information. Get the latest Idera Pharmaceuticals, Inc. IDRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of D. Style  IDRA: Idera Pharmaceuticals, Inc. - Earnings Announcements. Stay up to date with lastest View All Zacks #1 Ranked Stocks. Trades from $1. The Zacks Equity  Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results. 18 May 2018 Investors in Idera Pharmaceuticals (IDRA) need to pay close attention to the stock based on moves in the options market lately. 10 May 2019 The stock has moved higher by 25% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance 

IDRA - Idera Pharmaceuticals, Inc. Summary, Stock Quote ...

Idera Pharmaceuticals Inc (NASDAQ:IDRA) Expected to Post ... Brokerages expect Idera Pharmaceuticals Inc (NASDAQ:IDRA) to report earnings of ($0.33) per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Idera Pharmaceuticals’ earnings. The lowest EPS estimate is ($0.41) and the highest is ($0.21). Idera IDRA Price Target and Analyst Ratings (Idera Pharmaceuticals) Nov 04, 2019 · Their average twelve-month price target is $8.00, suggesting that the stock has a possible upside of 463.38%. The high price target for IDRA is $9.00 and the low price target for IDRA is $7.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy." Idera Pharmaceuticals, Inc. (IDRA) stock price, quote ... Idera (IDRA) closes enrollment in the late-stage ILLUMINATE-301 study, evaluating the combo of tilsotolimod plus Yervoy in patients with anti-PD-1 refractory advanced melanoma. Simply Wall St. Does Idera Pharmaceuticals, Inc.'s (NASDAQ:IDRA) CEO Salary Compare Well With Others? Vinnie, Vin Milano

View Idera Pharmaceuticals, Inc. IDRA investment & stock information. Get the latest Idera Pharmaceuticals, Inc. IDRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Options Traders Expect Huge Moves In Idera Pharmaceuticals ... Stocks Analysis by Zacks Investment Research covering: Netflix Inc, Idera Pharmaceuticals Inc. Read Zacks Investment Research's latest article on Investing.com. Breaking News. Idera Pharmaceuticals - 24 Year Stock Price History | IDRA ... Historical daily share price chart and data for Idera Pharmaceuticals since 1996 adjusted for splits. The latest closing stock price for Idera Pharmaceuticals as of March 13, 2020 is 1.18.. The all-time high Idera Pharmaceuticals stock closing price was 4361.60 on January 31, 1996.; The Idera Pharmaceuticals 52-week high stock price is 4.19, which is 255.1% above the current share price. IDRA - Idera Pharmaceuticals Inc Stock quote - CNNMoney.com Find real-time IDRA - Idera Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.

Idera Pharmaceuticals - IDRA - Stock Price & News | The ...

Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Idera Pharmaceuticals, Inc. (IDRA) in Focus: Stock Stock ... Mar 31, 2014 · Idera Pharmaceuticals, Inc. (IDRA) in Focus: Stock Stock Surges 17.8%. Zacks Equity Research . Zacks. 31 March 2014. Reblog. Share. Tweet. Share. ADAP Adaptimmune Therapeutics — Stock Price ... - StockTwits Apr 03, 2020 · Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. IDRA Stock | Message Board | Idera Pharmaceuticals ...

Jan 01, 2010 · Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and

Idera Pharmaceuticals, Inc. - TheStreet - Stock Market Idera Phamaceuticals (IDRA) Stock Jumping Following New Coverage. By Kurumi Fukushima. Jun 15, 2015 11:01 AM EDT. STOCKS. Analysts' Actions -- EMC, Lowe's, Micron and More. By TheStreet Staff. Options Traders Expect Huge Moves In Idera Pharmaceuticals ... Stocks Analysis by Zacks Investment Research covering: Netflix Inc, Idera Pharmaceuticals Inc. Read Zacks Investment Research's latest article on Investing.com. Breaking News. Idera Pharmaceuticals - 24 Year Stock Price History | IDRA ... Historical daily share price chart and data for Idera Pharmaceuticals since 1996 adjusted for splits. The latest closing stock price for Idera Pharmaceuticals as of March 13, 2020 is 1.18.. The all-time high Idera Pharmaceuticals stock closing price was 4361.60 on January 31, 1996.; The Idera Pharmaceuticals 52-week high stock price is 4.19, which is 255.1% above the current share price.

IDRA | Idera Pharmaceuticals Inc. Profile | MarketWatch Nov 04, 2019 · Idera Pharmaceuticals Inc. company facts, information and stock details by MarketWatch. View idra business summary and other industry information. Zacks: Analysts Expect Idera Pharmaceuticals Inc (NASDAQ ... Wall Street analysts forecast that Idera Pharmaceuticals Inc (NASDAQ:IDRA) will report earnings of ($0.33) per share for the current quarter, Zacks reports. Zero analysts have made estimates for Idera Pharmaceuticals - IDRA - Stock Price & News | The ...